Andrew Rutter's Biography

Andrew Rutter, Senior Director, GlaxoSmithKline

I lead a team in GSK driven to change how we combine existing and emerging technologies to transform Manufacturing, including Continuous Manufacture. I am a member of ICH Q13 EWG as EPPIA Deputy Lead. An Engineer by training, my career has taken me from Petrochemical Manufacture, via Techno-Economic Consulting, to Pharmaceutical Manufacture.

The Broader Importance of Flow Chemistry to Manufacture of Pharmaceuticals

Thursday, 14 November 2019 at 10:00

Add to Calendar ▼2019-11-14 10:00:002019-11-14 11:00:00Europe/LondonThe Broader Importance of Flow Chemistry to Manufacture of PharmaceuticalsFlow Chemistry Asia 2019 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com

Flow chemistry’s importance to medicines manufacture goes far beyond enabling different (better) chemistry – it is about providing agility (and compliance) in how we design and build medicines supply chains. I will explore how flow chemistry builds to Continuous Manufacturing processes and how this approach supports agility in the supply of medicines. I will link this approach to advances in modularization and a digital twin of the process. This philosophy is equally applicable in Small and Large Molecule manufacture.

Add to Calendar ▼2019-11-14 00:00:002019-11-15 00:00:00Europe/LondonFlow Chemistry Asia 2019Flow Chemistry Asia 2019 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors